Therapeutic Exploratory Study of CWP-0403

NCT00888719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: CWP-0403 100mg
DRUG: placebo
DRUG: CWP-0403 50mg

Sponsor

JW Pharmaceutical